Trial
NCT03099486
Regorafenib Plus 5-Fluorouracil/Leucovorin Beyond Progression in mCRC
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Fox Chase Cancer Center
Collaborators
—
Condition
Colorectal Cancer
Intervention
Regorafenib
Why stopped
Administrative change
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-02-07